These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4812134)

  • 1. Identifying particle contaminants.
    Draftz RG; Graf J
    Bull Parenter Drug Assoc; 1974; 28(1):35-52. PubMed ID: 4812134
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of particulate matter in intravenous solutions using the Coulter counter.
    Blaug SM; Sarabia RE
    Bull Parenter Drug Assoc; 1975; 29(2):74-88. PubMed ID: 1120215
    [No Abstract]   [Full Text] [Related]  

  • 3. [Particle contamination of infusion solution and equipment].
    Hübner G
    Klin Anasthesiol Intensivther; 1977; (14):70-3. PubMed ID: 926692
    [No Abstract]   [Full Text] [Related]  

  • 4. Limitations in the use of HIAC for product particle counting.
    Chrai S; Clayton R; Mestrandrea L; Myers T; Raskin R; Sokol M; Willis C
    J Parenter Sci Technol; 1987; 41(6):209-14. PubMed ID: 3437371
    [No Abstract]   [Full Text] [Related]  

  • 5. Determining a time frame for sterility testing of intravenous admixtures.
    DeChant RL; Furtado D; Smith FM; Godwin HN; Domann DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1305-8. PubMed ID: 6751079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between drugs and plastic intravenous fluid bags. II. Leaching of chemicals from bags containing various solvent media.
    Moorhatch P; Chiou WL
    Am J Hosp Pharm; 1974 Feb; 31(2):149-52. PubMed ID: 4815847
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of fiber size distribution in parenteral solutions.
    Davis R; Karuhn R; Graf J; Stockham J
    Bull Parenter Drug Assoc; 1975; 29(2):98-109. PubMed ID: 1120216
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring contamination levels of in-use intravenous solutions using "total sample" techniques.
    Hanson AL; Shelley RM
    Am J Hosp Pharm; 1974 Aug; 31(8):733-5. PubMed ID: 4853252
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of three methods for detecting bacterial contamination in intravenous solutions.
    Hoffman KH; Smith FM; Godwin HN; Hogan LC; Furtado D
    Am J Hosp Pharm; 1982 Aug; 39(8):1299-302. PubMed ID: 6751078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitive method for the rapid detection of bacterial contaminants in intravenous fluids.
    Denyer SP; Lynn R
    J Parenter Sci Technol; 1987; 41(2):60-6. PubMed ID: 3598821
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of the particulate content of LVP using different test methods. Health Industry Manufacturer's Association.
    J Parenter Sci Technol; 1989; 43(5):200-3. PubMed ID: 2809926
    [No Abstract]   [Full Text] [Related]  

  • 12. [Control of foreign particle contamination of injectable solutions].
    Van Ooteghem M; Moës A
    J Pharm Belg; 1972; 27(4):493-504. PubMed ID: 4681079
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contents of admixture of iron in pharmaceutical raw material and injection solutions].
    Bugrim NA; Zatula EI
    Farm Zh; 1970; 25(1):54-6. PubMed ID: 5419006
    [No Abstract]   [Full Text] [Related]  

  • 14. Progress toward a preferred method of monitoring the sterility of intravenous admixtures.
    Akers MJ
    Am J Hosp Pharm; 1982 Aug; 39(8):1297. PubMed ID: 6751077
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of three methods for detecting low-level bacterial contamination in intravenous solutions.
    Miller CM; Furtado D; Smith FM; Godwin HN; Hogan LC; Letendre DE
    Am J Hosp Pharm; 1982 Aug; 39(8):1302-5. PubMed ID: 6812414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particulate matter in cephalosporin injections.
    Mioduch HJ; Czaplicki AD; Schulz BG
    Am J Hosp Pharm; 1983 Nov; 40(11):1982-3. PubMed ID: 6650530
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of a simple method for predicting the levels of di(2-ethylhexyl) phthalate migrated from PVC medical devices into pharmaceutical solutions.
    Haishima Y; Seshimo F; Higuchi T; Yamazaki H; Hasegawa C; Izumi S; Makino T; Nakahashi K; Ito R; Inoue K; Yoshimura Y; Saito K; Yagami T; Tsuchiya T; Nakazawa H
    Int J Pharm; 2005 Jul; 298(1):126-42. PubMed ID: 15916874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Particulate matter in intravenous infusion fluids--phase 3.
    Turco SJ; Davis NM
    Am J Hosp Pharm; 1973 Jul; 30(7):611-3. PubMed ID: 4715106
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-destructive optical screening method for particulate matter in intravenous solutions.
    Passl WJ; Rumsey N; Trotter A
    Analyst; 1980 May; 105(1250):512-5. PubMed ID: 7396221
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of particulate matter in I.V. infusion fluids.
    Davis NM; Turco S; Sivelly E
    Am J Hosp Pharm; 1970 Oct; 27(10):822-6. PubMed ID: 5473472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.